Patients with LAM (lymphangioleiomyomatosis) or other rare lung diseases can lose their exercise capacity because of dyspnea and decreased lung function.… Read more »
Dr. Kai-Feng Xu is a Professor of Pulmonary Medicine at Peking Union Medical College Hospital, Beijing, China. His research interests are rare lung diseases including lymphangioleiomyomatosis (LAM), pulmonary alveolar proteinosis, cystic fibrosis, and others. He is the director of China’s Alliance for Rare Lung Diseases. Dr. Xu is currently a Section Editor for Orphanet Journal of Rare Diseases.